“Function-First” Lead Discovery: Mode of Action Profiling of Natural Product Libraries Using Image-Based Screening  by Schulze, Christopher J. et al.
Chemistry & Biology
Resource‘‘Function-First’’ Lead Discovery: Mode
of Action Profiling of Natural Product Libraries
Using Image-Based Screening
Christopher J. Schulze,1 Walter M. Bray,2 Marcos H. Woerhmann,3 Joshua Stuart,3 R. Scott Lokey,2
and Roger G. Linington1,*
1Department of Chemistry and Biochemistry
2Chemical Screening Center
3Department of Biomolecular Engineering
University of California Santa Cruz, Santa Cruz, CA 95064, USA
*Correspondence: rliningt@ucsc.edu
http://dx.doi.org/10.1016/j.chembiol.2012.12.007SUMMARY
Cytological profiling is a high-content image-based
screening technology that provides insight into the
mode of action (MOA) for test compounds by directly
measuring hundreds of phenotypic cellular features.
We have extended this recently reported technology
to the mechanistic characterization of unknown
natural products libraries for the direct prediction of
compound MOAs at the primary screening stage.
By analyzing a training set of commercial com-
pounds of known mechanism and comparing these
profiles to those obtained from natural product
library members, we have successfully annotated
extracts based on MOA, dereplicated known com-
pounds based on biological similarity to the training
set, and identified and predicted theMOA of a unique
family of iron siderophores. Coupled with traditional
analytical techniques, cytological profiling provides
an avenue for the creation of ‘‘function-first’’ ap-
proaches to natural products discovery.
INTRODUCTION
Historically, natural products have been a rich source of lead
compounds for drug development against a wide array of biolog-
ical targets. Currently, over half of all Food and Drug Administra-
tion (FDA)-approved drugs are derived either directly or indirectly
from natural sources. However, the role of natural products in
the pharmaceutical industry has been in steady decline over
the past two decades, due in large part to the shift toward
high-throughput screening (HTS) of synthetic libraries because
of the difficulties associated with deconvoluting biologically
active components from complex natural product extracts
(Koehn and Carter, 2005). One area where natural products
continue to be of high value is in the discovery of antitumor
drugs. Since 1940, almost 75% of approved small molecules
for the treatment of cancer have been either natural products,
semisynthetic derivatives of natural product scaffolds, or syn-
thetic compounds inspired by natural products pharmacophores
(Newman and Cragg, 2012). The field of marine natural productsChemistry & Biology 20, 285has found recent success in this area, with 15 marine natural
product-inspired compounds either approved by the FDA or in
clinical trials for the treatment of cancer (Gerwick and Moore,
2012). These data suggest that as the field continues to develop,
marine-derived natural products will be a growing resource for
the discovery of novel anticancer agents.
Broadly speaking, all drug discovery screening campaigns
can be categorized into one of two approaches: target-based
screening against specific molecular targets, or whole cell-
based screening to reach defined biological end points (Koehn
and Carter, 2005). Although natural products occupy a diverse
array of chemical space compared to synthetic combinatorial
libraries (Lachance et al., 2012), natural product extracts are
not particularly well suited to target-based HTS. They pose
many challenges to HTS platforms, the most significant of which
is that extracts contain mixtures of compounds of unknown
concentration, which can significantly complicate biological
readouts (Harvey, 2007). In addition, hits from target-based
HTS often fail to elicit the desired biological response in whole-
cell systems due to poor pharmacokinetic properties. By
contrast, efficacy can be readily confirmed in whole-cell screens,
but these provide no information about mode of action (MOA),
making hit prioritization and optimization challenging (Swinney
and Anthony, 2011).
Several new advances in screening technologies have been
developed with the goal of unifying these two approaches.
One such technique, cytological profiling (CP), uses automated
fluorescence microscopy to interrogate the physiological and
phenotypic effects of test compounds on cellular development
(Perlman et al., 2004; Mitchison, 2005; Young et al., 2008; Su-
therland et al., 2011). By using biologically relevant fluorescent
markers, MOA predictions can be made based on the pheno-
typic ‘‘fingerprint’’ of the cells. In addition, it is possible to cluster
compounds by MOA based on their cytological profiles, given
that compounds with similar modes of action elicit similar phys-
iological responses (Young et al., 2008). A conceptually similar
technique, the Connectivity Map, has been developed by the
Broad Institute to predict the MOAs for small molecules based
on transcriptional analysis, rather than fluorescent markers
(Lamb et al., 2006).
We have applied a modified cytological profiling platform to
our library of marine natural product prefractions with the objec-
tives of (1) annotating cytotoxic compounds in the library based–295, February 21, 2013 ª2013 Elsevier Ltd All rights reserved 285
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Cytological Profiling Natural Products Discoveryon their MOAs, (2) dereplicating prefractions based on compar-
ison of MOAs to a library of known compounds, and (3) probing
prefractions with unique CP fingerprints for the presence of
novel antitumor compounds. Although this technology has
previously been used to profile pure natural products (Young
et al., 2008) and to probe extracts for specific biological activi-
ties (Sumiya et al., 2011), this study shows that cytological
profiling can be implemented in screening large libraries of
natural product mixtures of unknown chemical composition.
Overall, the results of this study show that natural product
prefractions can be accurately clustered based on mode of
action, and that prefractions containing the same compounds
both cluster together, and cluster with matching reference
compounds from the training set. We have shown that prefrac-
tions containing different compounds that act by similar mech-
anisms share diagnostic and readily identifiable phenotypic
fingerprints, and that this platform can therefore be used to
characterize screening library members by MOA. We can also
identify clusters of prefractions that do not share significant
similarity to any of our reference compounds, which can be
selected as high priority for future study. Finally, this technology
has been used to discover and predict the mode of action of
a family of previously undescribed siderophores, microferriox-
amines A–D (1–4).
RESULTS
Cytological Profiling of a Known Compound Library
with Annotated Modes of Action
In order to verify the efficacy of our cytological profiling platform,
we first screened a library of 480 small molecules from the Har-
vard Institute of Chemistry and Cell Biology (ICCB) collection.
The library contains compounds that affect a variety of known
cellular targets, including the cytoskeleton, protein synthesis,
kinases, nuclear hormone receptors, ion channels, andG protein
coupled receptors, among others. Automated image analysis
generated a score for 250 cellular features (Table S1 available
online) corresponding to shape, intensity, and size for both
individual cells and well averages, and was performed as previ-
ously described (Young et al., 2008). Taken together, these
scores generate a cytological profile for each compound
screened (Supplemental Experimental Procedures). These data
identified 21 discrete mechanistic/target classes from the
480-member library that displayed intraclass Pearson correla-
tions that were significantly higher than extra-class pairwise
similarities (p < 0.0001). These data validated the ability of our
cytological profiling platform to cluster pure compounds by
mechanistic class.
Cytological Profiling of Marine Natural Product
Prefractions
To evaluate the suitability of cytological profiling for the charac-
terization of natural products mixtures, a library of 624 marine-
derived bacterial prefractions were evaluated using the
approach described above. To prepare this library, six prefrac-
tions were generated from each crude extract using C18 solid
phase extraction cartridges to give screening materials of
reduced complexity, containing an estimated 2–20 compounds
per prefraction. Following screening and imaging, feature scores286 Chemistry & Biology 20, 285–295, February 21, 2013 ª2013 Elsewere calculated by divergence from internal control wells in each
plate. The data acquired from the ICCB library and the 624
natural product prefractions were combined and clustered using
Cluster 3.0. Clustered data were visualized as a dendrogram
using Java TreeView (Figure 1A).
From this dendrogram, seven prominent clusters were
selected for further investigation based on the internal similarity
of their cytological profiles by Pearson correlation (Figure 1A).
In most instances, clusters contained both natural product
prefractions and known compounds from the ICCB library,
suggesting that active constituents from the natural product
prefractions should target similar cellular structures or path-
ways to the ICCB compounds in the same cluster. To test
this hypothesis, select prefractions from each cluster were
analyzed by liquid chromatography-tandem mass spectrometry
(LC-MS) and nuclear magnetic resonance (NMR) spectroscopy
and the structures of active constituents determined as out-
lined below.
Prediction of Compound Modes of Action Using
Cytological Profiling
One of the most readily identifiable clusters is Cluster A (Fig-
ure 1B). This cluster has a distinctive phenotype that results
from DNA modulation and/or arrest of the cell cycle. The set of
fluorescent stains employed in this study is particularly well
suited to detecting effects on cell cycle progression. These
probes include 5-ethynyl-20-deoxyuridine (EdU), which is
incorporated into the nascent DNA strand in S phase and sub-
sequently visualized by copper-mediated Click coupling to
rhodamine azide, and a mouse antiphospho-histone H3 (pHH3)
antibody visualized with anti-mouse Cy5-conjugated rabbit anti-
body to identify cells actively undergoing mitosis. Strongly nega-
tive deviations from the control wells in Cluster A for both EdU
and pHH3 resulted in the formation of a cluster of compounds
that cause cell-cycle arrest. In addition, this cluster showed posi-
tive deviations from control wells in nuclear shape and size
features, which is attributable to the lack of mitotic cells with
condensed chromatin in these wells. Many of the ICCB com-
pounds that are expected to affect DNA synthesis or transcrip-
tion, such as actinomycin D, aphidicolin, mitomycin C, and
camptothecin are tightly correlated in Cluster A.
Preliminary analysis of the natural product prefractions in this
cluster sought to determine if they contained compounds that
were consistent with this phenotype, but not represented in the
ICCB library. An automated fraction collection strategy, which
uses LC-MS to simultaneously separate and collect the eluent
directly into 96-well plates at 1 min intervals, was employed to
examine a subset of these prefractions. This fractionation
strategy simultaneously acquires retention time, UV absorbance,
and mass spectrometric data for all components in the prefrac-
tion, providing a detailed chemical annotation to compliment the
biological annotation. These ‘‘peak libraries’’ were rescreened
using the standard CP platform, with recapitulation of the perti-
nent phenotypes in specific wells providing direct identification
of the active constituents from the LC-MS trace.
The peak library of prefraction 1516D showed a single active
peak (Figure 2A) with a UV absorbance profile consistent with
a chromophore containing an extended conjugation system.
Purification of this peak by C18 reverse-phase high-performancevier Ltd All rights reserved
 1476C 
 1476F 
 1476D 
 1476E
 1533D 
 1538D
 1498D
 1498F 
 1535F
 1533F 
 1538F 
 1498C
 1535D 
 1507E
 1509C 
 1520C
 1500F 
 1494D 
 1500D
 Bafilomycin A1- 0.04 µM 
 Bafilomycin A1- 0.21 µM 
 1531F 
 1499E 
 1499F
 1515D 
 1515F 
 1492A
 1515E 
 1519E 
 1525F 
 1519D 
 1504D 
 1519C 
 1526E 
 1496D 
 1503B 
 1496E 
 1525D 
 1523E
 1490D
 1525E 
 1497E 
 1507D 
 Actinomycin D- 72 µM 
 Camptothecin- 96 µM 
 10-Hydroxycamptothecin-18.2 µM 
 Mitomycin C- 19.9 µM 
 Aphidicolin- 98.6 µM 
 Aphidicolin- 19.6 µM 
 Anisomycin- 1.0 µM 
 10-Hydroxycamptothecin- 0.73 µM
 Mitomycin C- 3.98 µM 
 1516D 
 1522D 
 1524A 
 1524C 
 1537F
 1533A
 1535B
 1522E
 1503C
 1503D 
 10-Hydroxycamptothecin- 91 µM
 1466D
 GF-109203X- 16 µM 
 1478C 
 1457E 
 1478B 
 1477E 
 1478D 
 Staurosporine- 0.57 µM 
 Staurosporine- 2.86 µM
 Ionomycin-9.8 µM 
 LY-83583- 26.7 µM 
 Staurosporine- 14.3 µM 
 1502E 
 1504E
 1502D 
 1502F
 1530D
 1530E
 1505E
 1530C
 1502C 
 1526C
 1505D
 1526D 
 1530F
 1526F 
 1513D 
 1513E
 1459D
 1444E
 1444D 
 1444F
 Valinomycin- 0.2 µM
 Valinomycin- 1.2 µM 
 Hoechst  33342- 2.4 µM 
 LY-83583 - 1.0 µM 
 Puromycin -0.47 µM
 Z-Leu3-VS- 0.47 µM 
 1485C
 1483C 
 1483E 
 1478F 
 1483D 
 1506C 
 1523D 
 Manoalide - 16 µM 
 Rottlerin - 12.9 µM 
 Valinomycin -6 µM
Features
C
om
po
un
ds
Cluster A
Cluster B
Cluster C
Cluster D
Cluster E
Cluster F
Cluster G
Clusters C and G
Cluster A
Cluster E
Cluster D
Cluster F
Cluster B
A B
 -1  0  +1 
Figure 1. Heat Map Depicting Cytological Profiling Dendrogram with Pertinent Clusters Highlighted
(A) Complete data set of 624 marine natural product prefractions and 1,920 discrete samples from the ICCB collection (480 compounds at four dilutions).
Individual compounds are presented on the y axis with individual features on the x axis.
(B) Detailed view of clusters A–G. Inmost instances, clusters contained both natural product prefractions and reference compounds from the ICCB library. Cluster
A has been truncated in order to highlight the specific prefractions that were analyzed.
See also Figure S1and Table S1.
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Cytological Profiling Natural Products Discoveryliquid chromatography (RP-HPLC) yielded a yellow amorphous
solid, which exhibited a similar CP fingerprint to the prefraction
(Figure S2). Analysis by (+)-FTICR MS (observed [M + Na]+
at m/z 1107.4664) and interpretation of one- and two-dimen-
sional NMR experiments (Supplemental Experimental Proce-
dures) identified this compound as the known antitumor agent,
mithramycin (Grundy et al., 1953; Wohlert et al., 1999), which
was confirmed via LC-MS by coinjection with an authenticChemistry & Biology 20, 285sample of mithramycin A (Figure S2). In order to corroborate
the cytological profiling fingerprint exhibited by 1516D, images
from this well were examined and found to exhibit very low levels
of EdU and pHH3 staining, which is characteristic of cells in
mitotic arrest (Figure 2B). Mithramycin is known to reversibly
bind to the minor groove of GC-rich regions of DNA in the
presence of Mg2+, inhibiting DNA and RNA polymerase activity
(Mansilla et al., 2010). In addition, the specificity for GC-rich–295, February 21, 2013 ª2013 Elsevier Ltd All rights reserved 287
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Figure 2. Identification andMOACharacter-
ization of Prefraction 1516D from Cluster A
(A) HPLC trace (280 nm) and CP profiles for each
time slice for the peak library of prefraction 1516D.
CP dendrogram presented with individual features
on the y axis, and time slices on the x axis. The
active wells (minutes 42–44) showed a decrease in
both EdU and pHH3 staining (highlighted with red
box), that matched the CP fingerprint for the
original prefraction. The blue features at minute
70 correspond to an unidentified media compo-
nent contaminant that elutes at the end of the
LC-MS trace.
(B) Full CP fingerprint and expansions of key
individual features for prefraction 1516D. These
expansions reveal strong negative deviations from
control wells for features corresponding to DNA
synthesis (EdU) and mitotic cells (pHH3). In addi-
tion, positive deviations from control wells are
observed for features corresponding to nuclear
size and shape, which is characteristic of cell-
cycle exit at G1/S. Analysis of the fluorescent
images confirmed the phenotype predicted by the
CP profile (blue, Hoechst; cyan, EdU; pink, pHH3).
See also Figure S2.
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Cytological Profiling Natural Products Discoveryregions prevents the transcription of numerous regulatory
proteins, including Sp1 family transcription factors, which
modulates the transcription of many genes necessary for cell
survival and differentiation (Remsing et al., 2003). The inclusion
of this extract in Cluster A is therefore supported by the pub-
lished molecular targets of mithramycin, all of which lead to
cell-cycle arrest.
Further analysis of prefractions in Cluster A led to the isolation
of resistomycin (Rosenbrook, 1967), resistoflavin (Eckardt et al.,
1979), and tetracenomycin D (Yue et al., 1986) from prefraction
1478D. Analysis of LC-MS data revealed that resistomycin was288 Chemistry & Biology 20, 285–295, February 21, 2013 ª2013 Elsevier Ltd All rights reservpresent in an additional two extracts
(1477E and 1494E), which are also
present in Cluster A. The identity of each
compound was verified by ()-FTICR
MS and analysis of NMR spectra (Fig-
ure S1). All three of these compounds
have reported cytotoxicity against mam-
malian cells (Martin et al., 2002; Gorajana
et al., 2007; Vijayabharathi et al., 2011).
Furthermore, resistomycin has recently
been shown to bind DNA by fluorescence
competition experiments and circular
dichroism studies (Vijayabharathi et al.,
2012), and to prevent transcription by
inhibition of RNA polymerase (Arora,
1985). Cytological profiling of a dilution
series of the pure compounds verified
that they cause cell-cycle arrest (Fig-
ure S1). The DNA binding and RNA
polymerase inhibition properties of resis-
tomycin are in accordance with the
MOAs exhibited by mithramycin and the
ICCB compounds in Cluster A, whichsupports the hypothesis that this cluster contains reference
compounds and prefractions that have similar MOAs.
Discovery of Microferrioxamines A–D
Investigation of the prefractions in Cluster A has resulted in the
isolation of compounds that have been previously reported to
interact with DNA, and therefore prevent cells from completing
the cell cycle. During this annotation process, prefraction 1522E
was identified as a prefraction that displayed a similar phenotype,
yet did not match known compounds from this cluster by LC-MS
analysis. Secondary screening of the peak library showed theed
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Figure 3. Identification and Characteriza-
tion of Microferrioxamines A–D (1–4) from
Prefraction 1522E
(A) HPLC trace (210 nm) and CP profiles for each
time slice for the peak library of prefraction 1522E.
CP dendrogram presented with individual features
on the y axis, and time slices on the x axis. The
original 1522E prefraction CP fingerprint is pre-
sented on the left for reference.
(B) Structures of microferrioxamines A–D (1–4)
and key COSY and HMBC correlations for the
connection of the alternating cadaverine and
succinyl units and the identification of the iso-
branched alkyl terminus. Structures were deter-
mined by one- and two-dimensional NMR, and
MSn experiments.
See also Figure S3 and Table S2.
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Cytological Profiling Natural Products Discoverypresence of four major compounds responsible for the biological
activity (Figure 3A). Isolation of these compounds by C18 RP-
HPLC, followed by (+)-FTICR MS, revealed that the four
compounds were structurally related, differing by 14 atomic
mass units (amu). In addition to the [M + H]+ signal, each of these
compounds exhibited a second mass adduct that differed by an
increase of 52.9 amu. Analysis of the isotope distributions for
these adducts, coupled with interpretation of the mass differ-
ences, identified this mass as [M + Fe  2H]+, suggesting that
these compounds had the capacity to chelate iron, which was
also verified by UV spectroscopy (Figure S3). Extensive one-
and two-dimensional NMR experiments (Table S2), coupled
withMSn analysis (FigureS3) led to thediscovery of four iron side-
rophores, microferrioxamines A–D (1–4) (Figure 3B). These
compounds are structurally similar to the recently reported side-
rophore promicroferrioxamine (Yang et al., 2011), with the C
terminus being iso-branched as opposed to the anteiso-
branched alkyl chain reported for promicroferrioxamine.
Iron siderophores, such as desferrioxamine (DFO), have been
previously reported to have antitumor activity by causing G1/S
arrest (Richardson et al., 2009). Iron depletion can have a variety
of effects in tumor cells suchas inhibition of ribonucleotide reduc-
tase,which is critical forDNAsynthesis, aswell as alterationof the
expression of multiple proteins that regulate the cell cycle, such
asp53,GADD45, cyclinD1, andp21CIP1/WAF1 (LiangandRichard-
son, 2003; Le and Richardson, 2004; Fu and Richardson, 2007;
Nurtjahja-Tjendraputra et al., 2007; Saletta et al., 2011). Although
structurally dissimilar to the DNA binding agents uncovered in
Cluster A, the phenotype observed in the cytological profiles of
microferrioxamines A–D is consistent with cells in G1/S arrest.
Discovery of this family of iron siderophores, and prediction of
their mode of action validates that CP can effectively cluster
compounds by MOA and demonstrates that this approach can
be successfully applied to the discovery of new compounds
without previously knowledge of their biological targets.Chemistry & Biology 20, 285–295, February 21, 2013Dereplication of Known
Compounds Based on Biological
Fingerprints
The ICCB library containsmany examples
of molecules with cellular targets that are
independent of cell-cycle regulation. Itwas expected that active compounds in our prefractions that
shared similar modes of action would cluster closely with these
known compounds, even if those targets were not directly exam-
ined by the fluorescent stain set. Therefore, we evaluated the
most prominent clusters that contained multiple natural product
prefractions and ICCB compounds to test the hypothesis that
CP could be used for the rapid dereplication of prefractions con-
taining known compounds.
Cluster B contains 19 natural product prefractions, and further
examination of the dendrogram in Figure 1 shows the closest
match to the ICCB training set is staurosporine, a pan-kinase
inhibitor (Omura et al., 1977). LC-MS analysis of these 19 pre-
fractions revealed that each also contained staurosporine,
a commonly encountered secondary metabolite produced by
Actinobacteria. Despite containing staurosporine at a range of
concentrations, the cytological fingerprint of these extracts is
sufficiently diagnostic for all of these prefractions to cluster
tightly together, indicating that this methodology can correctly
predict the presence of specific compound classes, even in
the absence of defined compound concentrations or fluorescent
stains that directly report on the target(s) of the active
compound.
Cluster C is phenotypically similar to Cluster A (cell-cycle
arrest), with the exception of the features that describe nuclear
shape. Cluster C has a strongly negative deviation from the
mean for these values, which signifies smaller condensed nuclei.
This suggests that many of the cells are apoptotic, which is
supported by evaluation of the fluorescent images showing
low cell count and a phenotype typical of apoptotic cells.
Analysis of the 13 prefractions in this cluster revealed that they
all contain complex mixtures of anthracyclines in high concen-
tration, as determined by their diagnostic UV profiles (Cowan
et al., 1997). As a representative example, cosmomycin D
(Ando et al., 1985) was isolated from prefraction 1498D, and its
structure confirmed by NMR experiments (Figure S1) andª2013 Elsevier Ltd All rights reserved 289
Figure 4. Cytological Profiles of Dilution
Series for Bafilomycin A1 from Both Pre-
fraction 1507E and ICCB Library and Com-
parison to Cytological Profile for Original
1507E Prefraction
Bafilomycin A1 was isolated and characterized
from prefraction 1507E. However, this prefraction
did not cluster with the references standards
of bafilomycin A1 (Figure 1B). Analysis of the
images revealed few viable cells in the well, which
precluded the generation of an accurate CP profile. Pure bafilomycin A1, isolated from 1507E, was screened in a dilution series and compared to the reference
standard concentrations of bafilomycin A1 in cluster D and prefraction 1507E. Purified bafilomycin A1 showed higher correlation to the reference standard
(Pearson correlation = 0.67) than to the original prefraction (Pearson correlation = 0.46). The clustered heat map can be viewed in Figure S4.
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Cytological Profiling Natural Products Discovery(+)-HRESITOFMS (observed [M + 2H]2+ at m/z 595.2996). The
exact mechanism of anthracycline cytotoxicity is complicated,
involving DNA intercalation and topoisomerase II poisoning. It
results in apoptosis, which is in line with the phenotype observed
through CP screening (Cipollone et al., 2002; Temperini et al.,
2005). Despite showing a phenotype consistent with apoptotic
cells, this cluster only contains anthracyclines, suggesting that
cell death associated with anthracycline toxicity results in a diag-
nostic phenotype that is identified by our cytological profiling
platform.
Cluster D exhibits multiple prefractions that cluster closely
with bafilomycin A1, a vacuolar ATPase-inhibitor (Werner et al.,
1984; Bowman et al., 1988). Analysis of these prefractions
confirmed the presence of bafilomycin A1 (observed [M + Na]+
at m/z 645.3993) in a subset of these samples (Supplemental
Experimental Procedures). Other extracts in this cluster ap-
peared to contain a biologically active compound that had
a similar UV profile and mode of action to bafilomycin A1. Isola-
tion of this compound and analysis by NMR and (+)-FTICR MS
(observed [M + Na]+ at m/z 838.4383) revealed that these
extracts contained bafilomycin B1 (Werner et al., 1984) (Fig-
ure S1). Although this analog has substantial additional structural
complexity compared to bafilomycin A1, it is has also been re-
ported to target vacuolar ATPases (Bowman et al., 1988), vali-
dating the presence of these prefractions in this cluster and
demonstrating that CP analysis can characterize compounds
by mode of action regardless of structural variation among
compounds that target the same cellular processes.
A final example of dereplication of known compounds based
on biological mode of action involved the isolation of valinomycin
(Brockmann and Schmidt-Kastner, 1955), a potassium channel
ionophore (Tosteson et al., 1967) from prefractions 1483D and
1483E, which are contained in Cluster E. This molecule was iso-
lated and characterized by (+)-FTICR MS (observed [M + Na]+ at
m/z 1133.6209) and one- and two-dimensional NMR experi-
ments (Figure S1). Although the cytological fingerprint of valino-
mycin is weaker than other clusters, close examination of the
dendrogram (Figure 1B) reveals that three concentrations of
valinomycin from the ICCB library cluster closely to both of these
prefractions, highlighting that CP screening can identify com-
pound classes, even when the mode of action for these com-
pounds is not related to the suite of fluorescent stains used to
obtain the structural features. This last result is significant, as it
demonstrates that the resolution of CP analysis extends well
beyond the small number of processes directly quantified by
the fluorescent stain set, and indicates that CP screening is290 Chemistry & Biology 20, 285–295, February 21, 2013 ª2013 Elsecapable of classifying compounds at significantly higher resolu-
tion than cell-cycle progression alone.
Analysis of Cluster F and G: Low Cell Count and
Deconvolution of Multiple Compounds per Prefraction
One of the inherent obstacles in screening of natural product
mixtures is that the concentration of the active constituent is
unknown. All of our prefractions are diluted to a set concentra-
tion prior to screening, based on empirical observations of
compound yields from liquid culture. However, although stan-
dardization of dilution volumes is a practical solution to the issue
of variablemetabolite yields frombacterial cultures, it does result
in the creation of stock solutions containing mixed concentra-
tions of test compounds. In cases where the actual concentra-
tion of test compounds is high, prefractions can cause complete
cell death, resulting in the absence of discernible phenotypes in
screening images. Fortunately, these clusters can be readily
identified by strongly negative deviations from the mean for
nearly all features, as represented by Clusters F and G. This
‘‘death phenotype’’ can be verified by examination of the nuclear
count for each well, with prefractions that cause substantial cell
death having very low nuclear count values compared with the
average for control wells.
Closer examination of cluster G revealed the presence of ba-
filomycin A1 from prefraction 1507E. This was initially in contrast
to our hypothesis that all prefractions containing bafilomycin A1
should be present in Cluster D. However, the low cell count in this
well precluded the generation of a diagnostic cytological finger-
print. Serial dilution of the bafilomycin A1 sample isolated from
prefraction 1507E, followed by cytological profiling, showed
that this compound exhibited a phenotypic dose-dependent
response that recapitulated the phenotype originally seen in
Cluster D when compared to the relevant concentrations of ba-
filomycin A1 from the ICCB library (Figures 4 and S4).
Another frequently encountered challenge with natural pro-
duct screening programs is the presence of multiple biologically
active compounds in a single prefraction. In cytological profiling,
this can result in CP fingerprints that do not represent theMOA of
either compound, complicating the accuracy of the clustering
approach. In the course of analyzing Cluster F, staurosporine
was found to be present in prefraction 1526E. However, 1526E
is separated from the staurosporine cluster (Cluster B), suggest-
ing that the CP fingerprint for 1526E could be the result of
the additive effects of two or more bioactive components. To
test this hypothesis, a peak library of this prefraction was gener-
ated to afford a one-compound-one-well library for secondaryvier Ltd All rights reserved
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Figure 5. Delineation of Individual Biological Fingerprints from Extracts Containing Multiple Bioactive Constituents
(A) HPLC trace (230 nm) and CP profiles for each time slice for the peak library of prefraction 1526E. CP dendrogram presented with individual features on the y
axis, and time slices on the x axis. Combined CP and LC-MS analyses reveal the presence of both staurosporine (minutes 2–4) and echinomycin (minutes 18–21),
as two active constituents with differing modes of action in the same prefraction. Examination of the individual cytological profiles for these two compounds
predicts that these compounds do not share the same MOA, and justifies the unique CP fingerprint observed for prefraction 1526E.
(B) Fluorescence microscopy screening images from primary screening and peak library plates. Images for staurosporine and echinomycin show marked
differences in cell morphology consistent with different MOAs. Both pure compound images differ from the phenotypes seen for both the original prefraction
(1526E) and the corresponding control well.
See also Figure S5.
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Cytological Profiling Natural Products Discoveryscreening. The strategy of employing peak library separation as
a secondary screen is advantageous, as it provides parallel
determination of the CP fingerprints for each individual compo-
nent of the prefraction in one screening event. Screening of the
peak library for 1526E revealed the presence of two bioactive
components, each of which possessed a discrete phenotype
(Figure 5A). One of these compounds was readily identified
as staurosporine by (+)-HRESITOFMS (observed [M + H]+ at
m/z 467.2076) and LC-MS, as well as the similarity of the
peak library CP fingerprint to the reference standard of stauro-
sporine from the ICCB library. Purification of the unknown
compound, characterization by (+)-HRESITOFMS (observed
[M + Na]+ at m/z 1123.4117), and assignment of one- and
two-dimensional NMR spectra revealed the presence of the
known bis-intercalator, echinomycin (Dell et al., 1975; Gilbert
and Feigon, 1991) (Figures 5A and S5). The peak library shows
a distinction between the phenotypes of staurosporine and
echinomycin as expected by their differing modes of action.
These results are further corroborated by examination of the
fluorescent images (Figure 5B), which clearly show phenotypic
divergence upon treatment with these two compounds. The
combination of CP and peak library screening is therefore
capable of deconvoluting complex natural product extracts
containing multiple biologically active compounds, and accu-
rately determining the precise phenotypic effect of individualChemistry & Biology 20, 285constituents, even as components of complex mixtures of
unknown concentration.
DISCUSSION
This study demonstrates the power of cytological profiling for
natural products drug discovery. In designing this initial study,
we sought to determine the suitability of CP for predicting
MOAs from complex natural product mixtures, and in doing so
to create a platform that would serve as a valuable tool for the
natural products discovery community. Although image-based
screening has previously been used to identify actin poisons
from sponge extracts (Sumiya et al., 2011), this example high-
lights the application of CP screening for the unbiased character-
ization of natural products libraries. Using CP we have been able
to generate detailed biological annotation of the prefractions in
our library at the primary screening stage. This approach has al-
lowed us to identify groups of prefractions that act by similar
MOAs, to dereplicate the library based on profile similarity to
a training set of known compounds, and has led to the discovery
and MOA prediction of the iron siderophores, microferriox-
amines A–D. This strategy improves upon standard cytotoxicity
assays, where the output is generally percent growth inhibition,
by allowing crucial, biology-driven triage decisions to be made
early in the discovery process. Although MOA information is–295, February 21, 2013 ª2013 Elsevier Ltd All rights reserved 291
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insight into the potential MOA of lead compounds at the primary
screening stage. This provides an opportunity to prioritize
subsets of prefractions from large libraries, and permits explicit
inclusion or exclusion of particular MOAs based on program-
matic screening priorities.
Arrest of the cell cycle (Cluster A) is one of the most readily
identifiable clusters in the dendrogram (Figure 1A). This is, in
part, due to the fact that our set of fluorescent probes is directly
observing the extent of DNA synthesis, the progression into
mitosis, and the size and shape of nuclei. However, both our pre-
fractions and the ICCB library contain compounds that act by
other distinct and diverse mechanisms. We are able to profile
compounds that act as kinase inhibitors (staurosporine), vacu-
olar ATPase inhibitors (bafilomycin A1 and B1), and K+ iono-
phores (valinomycin), despite not probing any of these features
directly. For example, mitochondrial swelling is one of the hall-
mark features of treatment of cells with valinomycin (Klein
et al., 2011). Although our stain set does not contain probes
that are specific for mitochondrial shape, the overall cellular
phenotype is sufficient for clustering prefractions containing
valinomycin with pure compound reference samples. In addition
to the aforementioned mechanisms, we can also identify other
clusters with clinically relevant MOAs, including actin and micro-
tubule poisons. However, none of the prefractions tested here
contained compounds that act by either of these mechanisms
and these phenotypes were therefore not investigated further.
As an extension to this technology, we can envision the creation
of customized stain sets that visualize the effects on specific
organelles, such as the mitochondria, golgi apparatus, or endo-
plasmic reticulum, which would enhance sensitivity for particular
features of interest.
In extending the CPmethodology to natural products libraries,
we were particularly interested to explore whether this tech-
nology could predict the modes of action for previously unchar-
acterized compounds. To this end, four structurally related iron
siderophores were isolated and characterized from prefraction
1522E in Cluster A. The discovery of this family of natural prod-
ucts highlights the ability of CP to aid in the discovery of novel
chemistry, and supports the hypothesis that CP clustering is
driven by biological MOA rather than structural similarity. In
many cases, we have observed clusters of prefractions that
contain the same molecule clustering closely with the respective
pure compound from the training set. This is the expected result;
however, it does not address the hypothesis that clustering is
based solely on compound MOA, regardless of similarity in
chemical structure. Although other compounds isolated from
prefractions in Cluster A, mithramycin and resistomycin, have
substantial structural differences, they both share flat aromatic
moieties that are known to interact with DNA. On the other
hand, cell-cycle arrest caused by the microferrioxamines is
presumably caused by intracellular iron chelation, which has
downstream effects on numerous proteins that regulate the
cell cycle. These molecules share little structural resemblance
to any other compounds found in Cluster A and are not thought
to interact directly with DNA. Yet their inclusion in Cluster A is
driven by the same cellular phenotype that is observed from
other compounds that have classically been known to cause
cell-cycle arrest.292 Chemistry & Biology 20, 285–295, February 21, 2013 ª2013 ElseAlthough CP is able to give an accurate picture of the general
mode of action for most compounds, it is unable to provide
a detailed output of the precise molecular target(s). Rather, it
allows for aMOA hypothesis to be formed at the outset, requiring
additional downstream biochemical experiments in order to
elucidate the molecular target for a given compound. This level
of detail represents a significant improvement over the live/
dead assays that are classically used to screen large natural
product libraries, and provides an opportunity to consider alter-
native approaches to natural products-based drug discovery.
Among these, prioritization of prefractions with low CP finger-
print similarity to the training set of known drugs provides an
avenue for discovering compounds that hit targets discrete
from those covered by current therapeutics. In addition, CP
screening has the potential to be used to identify compounds
that cause phenotypes similar to those generated by genetic
manipulation or siRNA treatment for specific pathways of
interest. The ability to garner MOA information from primary
screens therefore represents a valuable tool for natural products
drug discovery research programs.
It is pertinent to recognize the limitations of using cytological
profiling as a primary screen in natural products discovery, and
how we have attempted to overcome some of the inherent
obstacles that exist in using this strategy. One of the major chal-
lenges in any natural products screening platform is that the
concentrations of compounds in the library are largely unknown.
As CP profiles can be affected bywidely different concentrations
of active compounds, four concentrations of each compound in
the ICCB library were included to improve clustering with natural
product prefractions containing active compounds of unknown
titer. We generally observe two or three of these concentrations
clustering together, with the highest and lowest concentrations
resulting in cell death, or inactivity, respectively. This demon-
strates that CP fingerprints typically remain constant over a
wide concentration range, and that most compounds possess
broad concentration ranges that afford recognizable CP finger-
prints. When potent compounds exist in high titer, cell counts
become low, precluding the creation of informative cytological
profiles. However, these clusters can be readily identified and
screened again at appropriate dilutions by examining nuclear
count values. Serial dilution of prefractions of interest affords
dose-dependent phenotypes, which can be incorporated into
the data set to determine accurate positioning within the
dendrogram.
Another potential problem with CP screening concerns the
presence of multiple biologically active compounds in a single
prefraction. If the prefraction contains two compounds with
distinct MOAs, as seen in 1526E (Figure 5A), the cytological
profile will show divergence from both of the expected individual
profiles. Our approach allows the delineation of the activities of
multiple bioactive compounds by secondary screening of peak
libraries. Using this strategy, the CP profiles of each individual
compound in the prefraction can be obtained independently.
These independent profiles can then be reincorporated into the
main CP data set, and clustered with the reference library to
determine the accurate position in the dendrogram for each
compound.
Validation of CP for profiling natural products libraries sets the
stage for further applications in this area. Identification ofvier Ltd All rights reserved
Chemistry & Biology
Cytological Profiling Natural Products Discoverycompounds with defined MOA-specific fingerprints can be used
to expand chemical space in target areas where current thera-
peutic options are limited, or where current lead compounds
suffer from poor pharmacokinetic properties. This would best
be achieved through the inclusion of additional positive controls
in the training set to generate phenotypes for specific targets,
and comparison of these phenotypes to the CP results for
screening libraries. Alternatively, CP screening can be used to
identify prefractions with fingerprints that do not match
compounds from the training set. The presence of unique CP
fingerprints within the natural products library suggests that
either the prefraction contains multiple bioactive components,
in which case the true CP fingerprints can be determined using
peak library screening or, more excitingly, that the active constit-
uent does not act by any of the commonly encountered MOAs.
Determining this information confers a significant advantage in
selecting active prefractions for follow-up studies. We have
recently expanded this platform to our entire library of 3,168
marine natural product prefractions and have identified multiple
clusters of compounds that show divergence from the MOAs of
compounds in the ICCB training set. Although a unique finger-
print does not give an unequivocal indication of an unknown
MOA, it allows for hit prioritization that would be impossible by
considering cell viability alone. Follow-up studies on these pre-
fractions hold promise for the discovery of new antitumor natural
products that could have significance as chemical probes to
identify new targets or lead scaffolds for development as next-
generation therapeutics.
SIGNIFICANCE
Recent advances in image-based screening technologies
and data analysis strategies provide an opportunity to
expand the repertoire of methods used in natural products
discovery. We have applied amodified version of cytological
profiling to our library of marine-derived bacterial prefrac-
tions in order to gain biological information about their
modes of action at the primary screening stage. These
data have allowed for the prediction of modes of action for
specific compounds directly from prefractions, which have
been corroborated by the isolation of known compounds
that are consistent with these predictions. The use of CP
to interrogate unknown natural product prefractions is an
important step in the evolution of this technology, as it
opens the door for the discovery of new chemical scaffolds
while simultaneously offering evidence of their biological
significance. Highlighting this aspect, we have isolated
a structurally unique family of iron siderophores that are
predicted to causemitotic arrest by analysis of their cytolog-
ical profile. This prediction has been verified by profiling
of the pure compounds, and is supported by literature
precedence.
As natural products continue to produce structurally
diverse molecules with unique biological functions, we
envision that this platform will play an increasing role in
‘‘function-first’’ approaches to lead discovery. The number
of published natural product structures now stands at over
200,000, but the biological annotation of many of these
structures is limited. Therefore, there is currently an unex-Chemistry & Biology 20, 285plored opportunity to ascribe detailed biological functions
to many of these scaffolds and, in the process, to discover
the next generation of tools for both chemical genetic
studies, and lead compounds for future drug development.
EXPERIMENTAL PROCEDURES
Preparation of Peak Libraries
A 45 ml aliquot of prefraction DMSO stock was lyophilized and fractionated by
C18 reversed- phase HPLC (Phenomenex Synergi Fusion-RP, 10 3 250 mm
column, 2 ml min1 flow rate) using a MeOH/H2O (0.02% formic acid) solvent
system. Each prefraction was run on a gradient specifically tailored to produce
the most highly resolved chromatography. Eluent was collected into deep well
96-well plates using an automated time-based fraction collection method
consisting of 1 min time slices, and subsequently concentrated to dryness in
vacuo. Dried plates were resolubilized (10 ml DMSO per well), sonicated to
ensure homogeneity, reformatted to 384-well format and submitted for biolog-
ical screening.
Compound Transfer and Cell Culture
HeLa cells were plated into two clear-bottom 384-well plates (Corning) at
a density of 2,500 cells per well in 25 ml Dulbecco’s modified Eagle’s medium
(DMEM). The cells were incubated for 24 hr at 37C under 5% CO2. After this
incubation period, 150 nl of natural product prefractions in DMSO were trans-
ferred to the 384-well culture plates using the pin tool attachment on the Janus
MDT (Perkin-Elmer). The plates were transferred to 37C for 19 hr.
Cell Staining
After 19 hr of incubation, the two 384-well plates were treated with either
nuclear or cytoskeletal stain sets. For the nuclear stain set, 20 mM of
5-ethynyl-20-deoxyuridine (EdU) in DMEM was added to cells and incubated
for 1 hr at 37C. Cells were fixed with 4% formaldehyde for 20 min, washed
with PBS, treated with 0.5% Triton X-100 for 10 min, and washed with PBS.
Plates were blocked with a 2% BSA PBS solution for 20 min, washed with
PBS, and stained with rhodamine-azide using click chemistry by incubation
with 4 mM CuSO4, 2 mg/ml sodium ascorbate, and 1 mg/ml rhodamine azide
in 100 mM TRIS buffer for 30 min at 25C in the dark. After washing with
PBS, rabbit antiphospho-histone H3 (Millipore) in 2% BSA PBS was added
and the plate was incubated overnight at 4C. Plates were rinsed with PBS,
and Cy5 conjugated goat anti-rabbit antibody and Hoechst stain were added
for 1 hr in 2% BSA in PBS at 25C. The plates were then left in 0.1% azide in
PBS. For the cytoskeletal stain set, cells were fixed with 4% formaldehyde for
20 min, then washed with PBS. After treatment with 0.5% Triton X-100 for
10 min, the plates were washed with PBS and blocked with a 2% BSA PBS
solution. After washing with PBS, plates were incubated overnight at 4C
with FITC-conjugated mouse anti-a-tubulin and rabbit antiphospho-histone
H3 antibodies in 2% BSA PBS. After washing with PBS, Cy5-conjugated
goat anti-rabbit antibody, rhodamine-labeled phalloidin, and Hoechst stain
in 2% BSA PBS were added and plates were incubated for 1 hr at 25C. The
plates were then left in 0.1% azide in PBS.
Imaging and Image Analysis
The plates were imaged using an ImageXpress Micro epifluorescent micro-
scope (Molecular Devices) with a 103 Nikon objective lens. We obtained
four images per well for each wavelength in a plate resulting in 4,608 images
for the nuclear stain set and 6,144 images for the cytoskeletal stain set. The
plates were analyzed using MetaXpress (Molecular Devices). Measurements
were taken using built-in morphometry metrics, the multiwavelength cell
scoring, transfluor, and micronuclei modules. These measurements were
converted to feature scores, clustered using the Cluster 3.0 software, and
analyzed using Java TreeView.
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